Robert A. Winn Diversity in Clinical Trials: Clinical Investigator Leadership Award (Winn CILA)

Program Overview

The Robert A. Winn Diversity in Clinical Trials: Clinical Investigator Leadership Awards (Winn-CILA), supported by the Bristol Myers Squibb Foundation, are three-year career and leadership awards designed for oncology and cardiovascular graduates of the Winn CDA program.

The Winn CILA in Oncology (Winn CILA-Onc), powered by Conquer Cancer’s EveryGrant®, is designed to provide clinical cancer researchers with advanced clinical trials knowledge, leadership skills, mentorship, and sponsorship to succeed as independent clinical researchers, team members, and leaders. The training program is led by the American Society of Clinical Oncology  (ASCO) and includes collaboration with the National Cancer Institute’s National Clinical Trials Network (NCTN).

The Winn CILA in Cardiovascular Research (Winn CILA-CV), implemented by the American Heart Association (AHA), is designed to encourage diversity in cardiovascular clinical research. The program will enhance their abilities through advanced clinical trials knowledge, leadership skills, mentorship and sponsorship in order to prepare them to succeed as independent clinical researchers, team members and leaders as they conduct successful diverse clinical trials in the future.